share_log

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thompson Matthew

Vivos Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Thompson Matthew

Vivos Therapeutics | 4：持股變動聲明-董事 Thompson Matthew
美股sec公告 ·  06/28 20:57
Moomoo AI 已提取核心訊息
In a recent transaction, Matthew Thompson, associated with Vivos Therapeutics, Inc. [VVOS], executed a stock transaction on June 20, 2024. The specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting shareholding, were not disclosed. This event may be of interest to investors who follow Vivos Therapeutics, as insider transactions can provide insights into the company's financial health and future prospects.
In a recent transaction, Matthew Thompson, associated with Vivos Therapeutics, Inc. [VVOS], executed a stock transaction on June 20, 2024. The specific details regarding the nature of the transaction, such as the number of shares involved, the transaction price, and the resulting shareholding, were not disclosed. This event may be of interest to investors who follow Vivos Therapeutics, as insider transactions can provide insights into the company's financial health and future prospects.
在最近的一項交易中，與vivos therapeutics有關的馬修·湯普森（Matthew Thompson）於2024年6月20日進行了股票交易。具體交易細節，如涉及的股票數量、交易價格和結果的參股金融等未披露。此事件可能受到關注vivos therapeutics的投資者的關注，因爲內部交易可爲公司的財務健康和未來前景提供有見地的洞察。
在最近的一項交易中，與vivos therapeutics有關的馬修·湯普森（Matthew Thompson）於2024年6月20日進行了股票交易。具體交易細節，如涉及的股票數量、交易價格和結果的參股金融等未披露。此事件可能受到關注vivos therapeutics的投資者的關注，因爲內部交易可爲公司的財務健康和未來前景提供有見地的洞察。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息